The Manchester BRC is advertising nine specialised PhD studentships across a number of clinical and non-clinical areas. The deadline for applications is 2 February.
Professor Caroline Dive and Professor Chris Griffiths have been honoured by the Queen in the 2018 New Year’s Honours list.
This event in partnership with Manchester Precision Medicine Institute and Health Innovation Manchester will provide attendees with an understanding of precision medicine approaches and an overview of some of the existing research in this area across Manchester and within industry.
Professor Gareth Evans, Cancer Lead for the Manchester Biomedical Research Centre (BRC) outlines why this NIHR funding is so important to being able to deliver a personalised approach to disease treatment and prevention.
In April, Manchester patients had access to twice as many cancer trials*, as a result of a new strategic partnership across five CRUK Experimental Cancer Medicine Centres (ECMCs). This figure is likely to further increase as a result of the TARGET trial.
Researchers across Manchester have pulled together to open phase two of the TARGET cancer trial, which is on track to recruit over 100 patients in its first year. This is a significant achievement in the wake of the fire at the Paterson Building in April.
New test set to transform breast cancer prevention Women who have a family history of breast cancer are set to benefit from a new genetic test at Manchester University NHS Foundation Trust (MFT) that assesses breast cancer risk
The NIHR Manchester BRC, in collaboration with the NIHR Manchester CRF and supported by Oxford Road Corridor and Health Innovation Manchester is investing in the next generation of NHS researchers and want you to be part of it.